Literature DB >> 22198892

[Gastric MALT lymphoma: anatomo-clinical data and outcome of early stage H. pylori-associated gastric MALT-lymphoma resistant to treatment].

Ines Chelly1, Olfa Adouni, Sofiane Chouaib, Haifa Azouz, Haifa Nfoussi, Slim Haouet, Moncef Zitouna, Nidhameddine Kchir.   

Abstract

AIM: To describe the clinical, endoscopic and histological particularities of early stage HP associated gastric MALT lymphoma resistant to anti Hp treatment and identify predicting factors of resistance.
METHODS: We retrospectively studied 12 patients with primary low grade gastric localized MALT lymphoma treated with anti HP treatment and diagnosed at La Rabta Hospital from 1999 to 2009.
RESULTS: The ultrasonography was normal in 5 patients between the 6 responding patients. Perigastric lymph nodes were found in non responders (33.3%). Hp eradication was achieved in 66% of patients not responding while Hp was eradicated in 100% of responders. The two non-responding patients with failure of eradication of Hp had a strain resistant to Clarithromycin Hp.
CONCLUSION: Predicting factors of failure of anti HP: HP resistance to antibiotics, the proximal head, and the presence of perigastric lymph nodes. Recently, chromosomal aberrations and immune-histochemical markers have been implicated as factors of non response to anti Hp.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198892

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  1 in total

1.  New pharmaceutical treatment of gastric MALT lymphoma: anti-angiogenesis treatment using VEGF receptor antibodies and celecoxib.

Authors:  Masahiko Nakamura; Tetsufumi Takahashi; Hidenori Matsui; Shinichi Takahashi; Somay Y Murayama; Hidekazu Suzuki; Kanji Tsuchimoto
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.